Prof. Dr. med. Michael Flentje

Prof. Dr. med. Michael Flentje, the Director of Radiation Therapy at the University Hospital Wurzburg in Germany, is a highly esteemed doctor specializing in radiation therapy and oncology. With a strong focus on research and innovation in his field, Dr. Flentje has an impressive list of 842 scientific publications. Publications cover a wide range of topics, including the treatment of lung cancer, rectal cancer, and metastatic diseases using radiation therapy. Dr. Flentje's career is marked by numerous achievements and honors, including receiving the 2013 Alfred Breit Prize from the German Society for Radiation Oncology. His commitment to quality assurance and advancing treatment options is evident from his involvement in various multicenter trials, such as the RACE IT trial for bladder cancer and the DeLOS-II trial for laryngeal/hypopharyngeal cancer. Patients seeking radiation therapy and oncology treatment can benefit from Dr. Flentje's extensive experience and expertise. His dedication to research and his innovative approach to treatment makes him a valuable asset to the field of radiation oncology. As the Director of Radiation Therapy at University Hospital Wurzburg, Dr. Flentje is able to provide high-quality care to patients while also contributing to groundbreaking research in the field.